MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression

Ruozhen Hu1, Thomas B Huffaker, Dominique A Kagele

  • 1Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.

Insights

MicroRNA 155 (miR-155) is crucial for T helper 17 (Th17) cell function in autoimmune diseases. This study reveals miR-155 controls Th17 effector responses by regulating Ets1 and IL-23R, impacting experimental autoimmune encephalomyelitis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Diseases

Background:

  • T helper 17 (Th17) cells drive autoimmune pathogenesis.
  • MicroRNAs regulate Th17 cell development, but their role in effector functions is unclear.
  • miR-155 is a microRNA implicated in immune regulation.

Purpose of the Study:

  • To investigate the role of miR-155 in modulating Th17 cell effector functions.
  • To determine miR-155's involvement in the induction of experimental autoimmune encephalomyelitis (EAE).
  • To elucidate the molecular mechanisms by which miR-155 influences Th17 cell activity.

Main Methods:

  • Adoptive transfer of purified Th17 cells lacking miR-155 into recipient mice.
  • Induction of experimental autoimmune encephalomyelitis (EAE).
  • Gene expression profiling of miR-155 deficient Th17 cells.
  • Analysis of the IL-23-IL-23R signaling pathway.

Main Results:

  • Th17 cells deficient in miR-155 showed impaired ability to induce EAE.
  • miR-155 regulates the expression of effector genes in Th17 cells, including repression of the transcription factor Ets1.
  • Absence of miR-155 led to reduced IL-23R expression, causing hyporesponsiveness to IL-23.

Conclusions:

  • miR-155 plays a critical role in Th17 cell-mediated autoimmune inflammation.
  • The mechanism involves a signaling network including miR-155, Ets1, and the IL-23-IL-23R pathway.
  • Targeting miR-155 could be a therapeutic strategy for autoimmune diseases.